Drugs / Biologic lung volume reduction (BioLVR)
Biologic lung volume reduction (BioLVR)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00515164 | Aug 2007 → Apr 2008 | pulmonary emphysema | Aeris Therapeutics | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biologic lung volume reduction (BioLVR) | “Biologic lung volume reduction (BioLVR) is a new endobronchial treatment for advanced emphysema that reduces lung volume through tissue remodeling.” PMID 19179484 ↗ Jan 2009 |
| Known as | Biologic Lung Volume Reduction (BLVR) | “Biologic Lung Volume Reduction (BLVR) - 20 mL Hydrogel” NCT00515164 ↗ |
| Known as | Biologic Lung Volume Reduction (BLVR) - 20 mL Hydrogel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00515164 ↗ |
| Route | Other | “Patients are treated using a bronchoscope to direct treatment to the most damaged areas of the lung.” NCT00515164 ↗ |